查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1668184

藥用級碳酸鋰市場 - 全球產業規模、佔有率、趨勢、機會和預測，依純度（99%、99% 以上）、應用（緩釋、速釋）、地區和競爭細分，2020 年至 2030 年預測

Pharmaceutical Grade Lithium Carbonate Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Purity (99%, Above 99%), By Application (Extended Release, Immediate Release), By Region and Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 183 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024 年全球藥用級碳酸鋰市場價值為 1.4589 億美元，預計到 2030 年將達到 1.5297 億美元，預測期內的年複合成長率(CAGR) 為 3.75%。近年來，藥用級碳酸鋰市場顯著成長，主要原因是對鋰基藥物和療法的需求不斷成長。碳酸鋰是一種鋰鹽，在治療情緒障礙（特別是躁鬱症和憂鬱症）的藥物製劑生產中起著至關重要的作用。

市場概況
預測期 2026-2030
2024 年市場規模 1.4589億美元
2030 年市場規模 1.5297 億美元
2025-2030 年複合年成長率 3.75％
成長最快的領域 延長釋放
最大的市場 北美洲

這一市場成長歸因於多種因素，包括心理健康意識的提高、老年人口的增加以及對鋰在神經科學應用的持續研究。截至 2024 年 6 月，聯合國報告稱，已有 107 個國家（約佔全球溫室氣體排放量的 82%）承諾淨零排放。這項承諾正在刺激對先進儲能系統的需求，進而加速碳酸鋰市場的成長。藥用級碳酸鋰市場的穩定成長反映了製藥業的擴張和對鋰基情緒障礙治療的日益認可。

有幾個關鍵促進因素推動了這一成長，例如情緒障礙盛行率的上升、研發活動的增加以及碳酸鋰在藥物配方中的應用越來越多。該市場擴張的一個重要因素是人們對心理健康問題認知的不斷增強。隨著圍繞心理健康的討論和旨在應對這些挑戰的舉措越來越多，越來越多的人得到診斷，這推動了對包括碳酸鋰在內的有效藥物的需求。

此外，全球人口老化導致對碳酸鋰等藥物的需求增加，因為情緒障礙在老年人中更為常見。對鋰在神經科學和精神病學領域的潛在應用的持續研究進一步支持了市場的成長。根據世界衛生組織 2022 年 6 月的報告，全球每八人中就有一人患有擾亂思維、情緒調節或行為的精神障礙。

主要市場促進因素

心理健康意識不斷提高

主要市場挑戰

副作用和安全問題

主要市場趨勢

神經保護應用

目錄

第 1 章：產品概述

第 2 章：研究方法

第 3 章：執行摘要

第 4 章：顧客之聲

第5章：全球醫藥級碳酸鋰市場展望

  • 市場規模和預測
    • 按價值
  • 市場佔有率和預測
    • 按純度（99%、99% 以上）
    • 依應用分類（緩釋、速釋）
    • 按地區
    • 按公司分類（2024）
  • 市場地圖

第6章：北美醫藥級碳酸鋰市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 北美：國家分析
    • 加拿大
    • 墨西哥

第7章：歐洲醫藥級碳酸鋰市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 歐洲：國家分析
    • 英國
    • 義大利
    • 法國
    • 西班牙

第 8 章：亞太醫藥級碳酸鋰市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 亞太地區：國家分析
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：南美醫藥級碳酸鋰市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 南美洲：國家分析
    • 阿根廷
    • 哥倫比亞

第 10 章：中東和非洲醫藥級碳酸鋰市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • MEA：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第 11 章：市場動態

  • 驅動程式
  • 挑戰

第 12 章：市場趨勢與發展

  • 合併與收購（如有）
  • 產品發布（如果有）
  • 最新動態

第 13 章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的力量
  • 顧客的力量
  • 替代產品的威脅

第 14 章：競爭格局

  • Arcadium Lithium PLC
  • Albemarle Corporation
  • Jiangsu Lianhuan Pharmaceutical Co., Ltd.
  • American Elements
  • Jiangsu Nhwa Pharmaceutical Co., Ltd.
  • Panchsheel Organics Ltd (POLTD)
  • Blanver

第 15 章：策略建議

第16章 關於出版商,免責事項

簡介目錄
Product Code: 19577

The Global Pharmaceutical Grade Lithium Carbonate Market was valued at USD 145.89 million in 2024 and is projected to reach USD 152.97 million by 2030, growing at a compound annual growth rate (CAGR) of 3.75% during the forecast period. The market for pharmaceutical-grade lithium carbonate has seen significant growth in recent years, primarily driven by the increasing demand for lithium-based medications and therapies. Lithium carbonate, a lithium salt, plays a critical role in the production of pharmaceutical formulations used to treat mood disorders, particularly bipolar disorder and depression.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 145.89 Million
Market Size 2030USD 152.97 Million
CAGR 2025-20303.75%
Fastest Growing SegmentExtended Release
Largest MarketNorth America

This market growth is attributed to several factors, including rising mental health awareness, the expanding elderly population, and ongoing research into lithium's applications in neuroscience. As of June 2024, the United Nations reported that 107 countries, accounting for approximately 82% of global greenhouse gas emissions, have committed to net-zero pledges. This commitment is stimulating demand for advanced energy storage systems, which in turn is accelerating the growth of the lithium carbonate market. The steady growth of the pharmaceutical-grade lithium carbonate market reflects the expansion of the pharmaceutical sector and the increasing recognition of lithium-based treatments for mood disorders.

Several key drivers are contributing to this growth, such as the rising prevalence of mood disorders, growing research and development activities, and the increasing adoption of lithium carbonate in pharmaceutical formulations. A significant factor in this market's expansion is the growing awareness of mental health issues. With increasing discussions around mental health and initiatives aimed at tackling these challenges, more people are being diagnosed, which is driving demand for effective medications, including lithium carbonate.

Additionally, the aging global population is contributing to increased demand for pharmaceuticals like lithium carbonate, as mood disorders are more common among older individuals. Ongoing research into lithium's potential applications in neuroscience and psychiatric medicine further supports the market's growth. According to a June 2022 report by the World Health Organization, one in eight people globally experiences a mental disorder that disrupts thinking, emotional regulation, or behavior.

Key Market Drivers

Rising Mental Health Awareness

The pharmaceutical-grade lithium carbonate market is experiencing notable growth, largely driven by the increasing awareness of mental health issues. Lithium carbonate, primarily used to manage bipolar disorder, has gained attention as mental health awareness spreads and more individuals seek treatment for mood disorders. The increased recognition and the subsequent demand for lithium carbonate are crucial drivers of market expansion.

In recent years, there has been a significant shift in societal attitudes toward mental health, with greater emphasis on openly addressing and effectively managing mental health challenges. Advocacy campaigns, educational initiatives, and personal stories have contributed to reducing the stigma surrounding mental health conditions, encouraging individuals to seek help. As a result, more people are being diagnosed with mood disorders, depression, and bipolar disorder, further boosting demand for pharmaceutical treatments like lithium carbonate.

In May 2023, Livent announced a merger agreement with Allkem, a specialty lithium chemicals company, to form NewCo, a leading global producer of lithium chemicals. This merger will provide a diversified portfolio of low-cost assets across key geographies, product segments, and customer bases, with the deal expected to be finalized by the end of 2023.

Key Market Challenges

Side Effects and Safety Concerns

Safety concerns and potential side effects pose significant challenges to the global pharmaceutical-grade lithium carbonate market. While lithium carbonate offers substantial therapeutic benefits, particularly in the treatment of bipolar disorder and other mental health conditions, it is not without its challenges. Potential side effects can include gastrointestinal discomfort, tremors, and in some rare cases, kidney problems or thyroid dysfunction.

These side effects, along with the need for careful monitoring, require healthcare providers and patients to approach lithium treatment with caution. Furthermore, regulatory agencies around the world have implemented stringent monitoring and reporting requirements, adding complexity and cost to its pharmaceutical use. To address these challenges, the pharmaceutical-grade lithium carbonate market must focus on research and development to minimize side effects and enhance drug delivery systems. Additionally, educational initiatives should ensure safe and effective use, and ongoing collaboration between healthcare professionals, patients, and regulatory authorities is vital to balancing therapeutic benefits with safety.

Key Market Trends

Neuroprotective Applications

Research into the neuroprotective applications of lithium carbonate has emerged as a key trend in the global pharmaceutical-grade lithium carbonate market. Lithium carbonate, traditionally used in psychiatric treatment, is gaining attention for its potential neuroprotective properties. This trend is driven by the growing understanding of lithium's therapeutic benefits beyond its traditional role in managing mood disorders.

Researchers and pharmaceutical companies are increasingly exploring lithium carbonate's potential to protect neurons and potentially slow the progression of neurodegenerative diseases like Alzheimer's and Parkinson's disease. Studies suggest that lithium may influence various neuroprotective mechanisms, including reducing inflammation, promoting neurogenesis, and modulating neurotransmitter levels. As a result, there has been an increase in research and development investments aimed at creating lithium carbonate formulations specifically designed for neuroprotection.

With the global population aging and the incidence of neurodegenerative diseases rising, the demand for effective treatments and interventions continues to grow. The exploration of lithium carbonate's neuroprotective applications presents a promising opportunity for both pharmaceutical companies and patients seeking innovative therapies for neurological disorders. While further research is needed to fully understand its potential, the focus on neuroprotective properties highlights the dynamic nature of the pharmaceutical-grade lithium carbonate market and its potential to revolutionize the treatment of neurodegenerative diseases in the future.

Key Market Players

  • Arcadium Lithium PLC
  • Albemarle Corporation
  • Jiangsu Lianhuan Pharmaceutical Co., Ltd.
  • American Elements
  • Jiangsu Nhwa Pharmaceutical Co., Ltd.
  • Panchsheel Organics Ltd (POLTD)
  • Blanver

Report Scope

This report segments the Global Pharmaceutical Grade Lithium Carbonate Market into the following categories, along with an analysis of the key industry trends:

By Purity:

  • 99%
  • Above 99%

By Application:

  • Extended Release
  • Immediate Release

By Region:

  • North America (United States, Canada, Mexico)
  • Europe (France, United Kingdom, Italy, Germany, Spain)
  • Asia-Pacific (China, India, Japan, Australia, South Korea)
  • South America (Brazil, Argentina, Colombia)
  • Middle East & Africa (South Africa, Saudi Arabia, UAE)

Competitive Landscape

This section provides a detailed analysis of the major companies operating in the global pharmaceutical-grade lithium carbonate market.

Available Customizations

TechSci Research offers customized solutions for the global pharmaceutical-grade lithium carbonate market report to meet specific business needs.

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validations
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Pharmaceutical Grade Lithium Carbonate Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Purity (99%, Above 99%)
    • 5.2.2. By Application (Extended Release, Immediate Release)
    • 5.2.3. By Region
    • 5.2.4. By Company (2024)
  • 5.3. Market Map

6. North America Pharmaceutical Grade Lithium Carbonate Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Purity
    • 6.2.2. By Application
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Pharmaceutical Grade Lithium Carbonate Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Purity
        • 6.3.1.2.2. By Application
    • 6.3.2. Canada Pharmaceutical Grade Lithium Carbonate Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Purity
        • 6.3.2.2.2. By Application
    • 6.3.3. Mexico Pharmaceutical Grade Lithium Carbonate Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Purity
        • 6.3.3.2.2. By Application

7. Europe Pharmaceutical Grade Lithium Carbonate Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Purity
    • 7.2.2. By Application
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Pharmaceutical Grade Lithium Carbonate Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Purity
        • 7.3.1.2.2. By Application
    • 7.3.2. United Kingdom Pharmaceutical Grade Lithium Carbonate Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Purity
        • 7.3.2.2.2. By Application
    • 7.3.3. Italy Pharmaceutical Grade Lithium Carbonate Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Purity
        • 7.3.3.2.2. By Application
    • 7.3.4. France Pharmaceutical Grade Lithium Carbonate Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Purity
        • 7.3.4.2.2. By Application
    • 7.3.5. Spain Pharmaceutical Grade Lithium Carbonate Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Purity
        • 7.3.5.2.2. By Application

8. Asia-Pacific Pharmaceutical Grade Lithium Carbonate Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Purity
    • 8.2.2. By Application
    • 8.2.3. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Pharmaceutical Grade Lithium Carbonate Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Purity
        • 8.3.1.2.2. By Application
    • 8.3.2. India Pharmaceutical Grade Lithium Carbonate Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Purity
        • 8.3.2.2.2. By Application
    • 8.3.3. Japan Pharmaceutical Grade Lithium Carbonate Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Purity
        • 8.3.3.2.2. By Application
    • 8.3.4. South Korea Pharmaceutical Grade Lithium Carbonate Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Purity
        • 8.3.4.2.2. By Application
    • 8.3.5. Australia Pharmaceutical Grade Lithium Carbonate Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Purity
        • 8.3.5.2.2. By Application

9. South America Pharmaceutical Grade Lithium Carbonate Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Purity
    • 9.2.2. By Application
    • 9.2.3. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Pharmaceutical Grade Lithium Carbonate Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Purity
        • 9.3.1.2.2. By Application
    • 9.3.2. Argentina Pharmaceutical Grade Lithium Carbonate Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Purity
        • 9.3.2.2.2. By Application
    • 9.3.3. Colombia Pharmaceutical Grade Lithium Carbonate Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Purity
        • 9.3.3.2.2. By Application

10. Middle East and Africa Pharmaceutical Grade Lithium Carbonate Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Purity
    • 10.2.2. By Application
    • 10.2.3. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Pharmaceutical Grade Lithium Carbonate Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Purity
        • 10.3.1.2.2. By Application
    • 10.3.2. Saudi Arabia Pharmaceutical Grade Lithium Carbonate Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Purity
        • 10.3.2.2.2. By Application
    • 10.3.3. UAE Pharmaceutical Grade Lithium Carbonate Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Purity
        • 10.3.3.2.2. By Application

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Porter's Five Forces Analysis

  • 13.1. Competition in the Industry
  • 13.2. Potential of New Entrants
  • 13.3. Power of Suppliers
  • 13.4. Power of Customers
  • 13.5. Threat of Substitute Products

14. Competitive Landscape

  • 14.1. Arcadium Lithium PLC
    • 14.1.1. Business Overview
    • 14.1.2. Company Snapshot
    • 14.1.3. Products & Services
    • 14.1.4. Financials (As Reported)
    • 14.1.5. Recent Developments
    • 14.1.6. Key Personnel Details
    • 14.1.7. SWOT Analysis
  • 14.2. Albemarle Corporation
  • 14.3. Jiangsu Lianhuan Pharmaceutical Co., Ltd.
  • 14.4. American Elements
  • 14.5. Jiangsu Nhwa Pharmaceutical Co., Ltd.
  • 14.6. Panchsheel Organics Ltd (POLTD)
  • 14.7. Blanver

15. Strategic Recommendations

16. About Us & Disclaimer